revenue growth

Sales of health products grew by 42 per cent on back of a strong momentum gained from new product introductions and territorial…

Total income in Q1FY23 at Rs 129.97 crore, up 24.4 per cent from Rs 104.4 crore in Q4FY22

Operating EBITDA grows by 16 per cent to Rs 190 crore

Profit After Tax (PAT) up 32 per cent YoY

For the year ending March 22, the revenues grew by 23.4 per cent at Rs 1502.7 crores, as against Rs 1217.4 crores, same period…

For the fourth quarter ended 31st March, 2022, the company reported consolidated income from operations of Rs 640 crores, up by…

In FY2022, the revenue from operations was of Rs 2,319 crores and Profit After Tax (PAT) grew from Rs 88 crores to Rs 193 crores

The company has delivered total sales of Rs 262 crores for the quarter ended 31st March, 2022 vs Rs 214 crores, up by 23 per cent…

Consolidated Profit Before Tax (PBT) at Rs 126.70 crores has risen by 29 per cent in FY22 and Profit After Tax (PAT) at Rs 101.68…

Company recommended dividend of Rs 10 per equity share i.e. 500 per cent